These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 28948481)

  • 21. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
    Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M;
    Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Device therapies: new indications and future directions.
    Kumar P; Schwartz JD
    Curr Cardiol Rev; 2015; 11(1):33-41. PubMed ID: 25391852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up.
    Stockburger M; Moss AJ; Klein HU; Zareba W; Goldenberg I; Biton Y; McNitt S; Kutyifa V
    Clin Res Cardiol; 2016 Nov; 105(11):944-952. PubMed ID: 27318807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
    Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
    Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome.
    Goldenberg I; Huang DT; Nielsen JC
    Eur Heart J; 2020 Jun; 41(21):2003-2011. PubMed ID: 31713598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.
    Freeman JV; Masoudi FA
    Heart Fail Clin; 2013 Jan; 9(1):59-77. PubMed ID: 23168318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
    Ansalone G; Ricci R; Cacciatore G; Santini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Device therapy of chronic heart failure: Update 2015].
    Israel CW; Ekosso-Ejangue L; Sheta MK
    Herz; 2015 Dec; 40(8):1121-32; quiz 1133-4. PubMed ID: 26631395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.
    Chia PL; Foo D
    Singapore Med J; 2016 Jul; 57(7):354-9. PubMed ID: 27440409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).
    Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Change in indication for cardiac resynchronization therapy?
    Lawin D; Stellbrink C
    Eur J Cardiothorac Surg; 2019 Jun; 55(Suppl 1):i11-i16. PubMed ID: 31106336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
    Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF
    Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term efficacy of implantable cardiac resynchronization therapy plus defibrillator for primary prevention of sudden cardiac death in patients with mild heart failure: an updated meta-analysis.
    Sun WP; Li CL; Guo JC; Zhang LX; Liu R; Zhang HB; Zhang L
    Heart Fail Rev; 2016 Jul; 21(4):447-53. PubMed ID: 27043219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.